Saturday June 23, 2018 21:20

Heathcare Press Release : 04 Jun 2018

Takeda Highlights Favorable Safety Profile of Entyvio(R) (vedolizumab) Through Comparative Heathcare—04 Jun 18

Takeda demonstrates leadership in GI by featuring new U.S. VICTORY Consortium data among its 24 sponsored Entyvio abstracts presented at the Digestive Disease Week (DDW) 2018 meeting Takeda Pharmaceutical Company Limited (TSE: 4502) ("Takeda") today

Merck Presents Update on Tepotinib in Advanced Lung Cancer at ASCO Heathcare—04 Jun 18

Tepotinib (c-Met kinase inhibitor): 9082, 9016; M7824 (TGF-ss trap/anti-PD-L1): 3007, 9017, 2566; M2698 (dual p70S6k/Akt inhibitor): 2584; M6620 (ATR inhibitor): 2549; M3814 (DNA-PK): 2518 Not intended for UK- or US-based media - Data from an ongoing